Zydus receives USFDA final approval for Azithromycin for Oral Suspension USP

Zydus Cadila has received the final approval from the USFDA to market Azithromycin for Oral Suspension USP (USRLD - Zithromax), 100 mg/5 mL and 200 mg/5 mL.

This medication contains Azithromycin, a macrolide antibiotic that fights bacteria. It is used to treat different types of bacterial infections such as respiratory infections, skin infections, ear infections and sexually transmitted diseases. This medication will not work for Viral infections such as common cold, flu etc. The drug will be manufactured at the group's formulations manufacturing facility at Baddi.

Powered by Capital Market - Live News